Diagnosing cancer

There has been a lot of excitement about the Galleri test, and it’s obvious to see why. Here are three things you need to about this multi-cancer blood test.

Meet two of the latest Primer Awardees and find out why forensic science and nanomaterials are, in fact, ideal backgrounds for cancer research

Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role.

Our researchers have developed specialised cameras to detect cancer cells that can be hard for both surgical cameras and the naked eye to spot.

The upcoming Early Detection of Cancer Conference brings together experts from multiple disciplines to share ground breaking research and progress in the field

1 in 2 people in the UK will be diagnosed with some form of cancer during their lifetime. We’ve estimated the impact different types of activity could make to ambitions to diagnose cancer earlier.

LGBTQ+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQ+ people.

Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.

A Cardiff University-led UK-wide survey has found that more than 1 in 5 people are less likely to take part in cancer screening than before the pandemic.

A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible.